India has become a leading global hub for pharmaceutical and life sciences Global Capability Centers (GCCs), with 23 of the top 50 global companies establishing operations in the country. Driven by a vast talent pool and significant investments, these GCCs have evolved from support functions to strategic centers for drug discovery, digital therapeutics, and AI-powered solutions. This shift positions India as indispensable to global R&D and end-to-end value creation, moving beyond mere cost arbitrage.

Source: Times of India